Currently, there are 1.64B common shares owned by the public and among those 1.25B shares have been available to trade.
The company’s stock has a 5-day price change of -7.04% and -3.90% over the past three months. CPNG shares are trading -0.23% year to date (YTD), with the 12-month market performance up to 24.53% higher. It has a 12-month low price of $17.67 and touched a high of $26.91 over the same period. CPNG has an average intraday trading volume of 7.91 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.46%, -6.48%, and -5.53% respectively.
Institutional ownership of Coupang Inc (NYSE: CPNG) shares accounts for 52.52% of the company’s 1.64B shares outstanding.
It has a market capitalization of $39.59B and a beta (3y monthly) value of 1.08. The stock’s trailing 12-month PE ratio is 264.54, while the earnings-per-share (ttm) stands at $0.08. The company has a PEG of 1.97 and a Quick Ratio of 0.89 with the debt-to-equity ratio at 0.91. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.91% over the week and 3.38% over the month.
Analysts forecast that Coupang Inc (CPNG) will achieve an EPS of 0.07 for the current quarter, 0.08 for the next quarter and 0.73 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.05 while analysts give the company a high EPS estimate of 0.05. Comparatively, EPS for the current quarter was 0.05 a year ago. Earnings per share for the fiscal year are expected to increase by 305.63%, and 123.36% over the next financial year.
Looking at the support for the CPNG, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on February 26, 2025, with the firm’s price target at $28.50. Bernstein coverage for the Coupang Inc (CPNG) stock in a research note released on October 07, 2024 offered a Outperform rating with a price target of $30. CLSA was of a view on September 04, 2024 that the stock is Outperform, while UBS gave the stock Buy rating on May 16, 2024, issuing a price target of $26. BofA Securities on their part issued Buy rating on May 03, 2024.
